Infinity Pharmaceuticals Inc (NASDAQ:INFI)
| 2.16 BATS BZX Real-Time Price As of 3:42pm ET |  -0.16 / -6.90%Today’s Change | 0.82 Today|||52-Week Range 5.98 | +1.89% Year-to-Date |
Latest INFI News | Press Releases
| Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Tops Revenue Estimates Jul 27 / Zacks.com - Paid Partner Content | Infinity Pharmaceuticals (INFI) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Jul 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.32 |
| Today’s open | 2.28 |
| Day’s range | 2.11 - 2.44 |
| Volume | 255,857 |
| Average volume (3 months) | 4,033,448 |
| Market cap | $203.9M |
Data as of 3:42pm ET, 07/30/2021
Growth & Valuation
| Earnings growth (last year) | +18.08% |
| Earnings growth (this year) | +14.19% |
| Earnings growth (next 5 years) | +8.50% |
| Revenue growth (last year) | -43.62% |
| P/E ratio | NM |
| Price/Sales | 73.82 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TCDATricida Inc | -0.46 | -11.33% |
| ---- | ||
| XERSXeris Pharmaceutical... | -0.10 | -3.15% |
| CKPTCheckpoint Therapeut... | -0.04 | -1.50% |
Data as of 3:43pm ET, 07/30/2021
Financials
| Next reporting date | November 9, 2021 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $1.7M |
| Annual profit (last year) | -$40.5M |
| Net profit margin | -2,355.56% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
